The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy.
Affiliation
Royal Victoria Eye and Ear Hospital, Adelaide Road, Dublin 2, Dublin, Ireland. max@treacy.ieIssue Date
2012-09MeSH
Diabetic RetinopathyEye
Fenofibrate
Humans
Hypolipidemic Agents
Injections
PPAR alpha
Treatment Outcome
Metadata
Show full item recordCitation
The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy. 2012, 12:46 BMC OphthalmolJournal
BMC ophthalmologyDOI
10.1186/1471-2415-12-46PubMed ID
22937835Additional Links
http://www.biomedcentral.com/content/pdf/1471-2415-12-46.pdfhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532122/pdf/1471-2415-12-46.pdf
Abstract
Systemic therapeutics targeting the peroxisome proliferator-activated receptors have been found to be beneficial in the treatment of diabetic retinopathy. In this paper, we provide a rationale for the use of these therapeutics as intraocular agents. In addition, we introduce the peroxisome proliferator-activated receptors and describe their functions in response to the drugs.Item Type
ArticleLanguage
enISSN
1471-2415ae974a485f413a2113503eed53cd6c53
10.1186/1471-2415-12-46
Scopus Count
Collections
Related articles
- The use of fenofibrate in the management of patients with diabetic retinopathy: an evidence-based review.
- Authors: Sharma N, Ooi JL, Ong J, Newman D
- Issue date: 2015 Jun
- Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
- Authors: Chen Y, Hu Y, Lin M, Jenkins AJ, Keech AC, Mott R, Lyons TJ, Ma JX
- Issue date: 2013 Jan
- The PPARalpha ligand fenofibrate: meeting multiple targets in diabetic nephropathy.
- Authors: Varghese Z, Moorhead JF, Ruan XZ
- Issue date: 2006 May
- The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs.
- Authors: Xu Y, Lu L, Greyson C, Rizeq M, Nunley K, Wyatt B, Bristow MR, Long CS, Schwartz GG
- Issue date: 2006 May
- Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
- Authors: Qiu F, Meng T, Chen Q, Zhou K, Shao Y, Matlock G, Ma X, Wu W, Du Y, Wang X, Deng G, Ma JX, Xu Q
- Issue date: 2019 May 6